• First fee per scan revenues generated for Salix® Coronary Plaque module with Tanner Health
• Tanner Health has successfully expanded their use of the Salix® Coronary Anatomy platform to include assessments with Salix® Coronary Plaque module
• Expands Artrya U.S. revenue opportunity with subscription revenues and fee per scan assessed with Salix® Coronary Plaque module

Artrya Limited (ASX: AYA), a medical technology company commercialising its Salix® AI-powered cloud platform, has announced that Tanner Health has commenced commercial use of the Salix® Coronary Plaque module, generating the first fee per scan revenues for Artrya. Tanner Health, a foundational U.S. commercial customer, has successfully expanded their use of the Salix® Coronary Anatomy platform to include assessments with Salix® Coronary Plaque module in their workflow. This expands Artrya's U.S. revenue opportunity with subscription revenues and fee per scan assessed with Salix® Coronary Plaque module, supported by U.S. Category 1 CPT reimbursement rate of US$950 for each assessment. The ease of activation within the Salix® Coronary Anatomy platform has been well received by the clinicians, and the back-end processes through to billing are also now established. Artrya looks forward to growing adoption across the entire Tanner Health network in the near term, which will generate an attractive ongoing fee to the company from each scan they assess.